Last reviewed · How we verify
Metisazon (metisazone)
Metisazon (generic name: metisazone) is a metisazone drug. It is currently in unknown development.
Metisazone works by inhibiting bacterial DNA synthesis, but the exact details of this process are not well understood.
Methisazone, also known as metisazone, is a small molecule antiviral drug that inhibits mRNA and protein synthesis, particularly in pox viruses. It was tested in the 1960s for its effectiveness against smallpox infection, but its use was limited due to logistical challenges in developing countries.
At a glance
| Generic name | metisazone |
|---|---|
| Drug class | metisazone |
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Think of it like a copy machine: metisazone blocks the machine's ability to make copies of the bacterial DNA, which ultimately stops the bacteria from growing and multiplying. This is a common way that antibiotics work, but more research is needed to fully understand how metisazone fits into this process.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metisazon CI brief — competitive landscape report
- Metisazon updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Metisazon
What is Metisazon?
How does Metisazon work?
What is the generic name of Metisazon?
What drug class is Metisazon in?
What development phase is Metisazon in?
Related
- Drug class: All metisazone drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing